Recently, various media outlets and institutions published rankings and special features spotlighting women on the front lines of venture capital and outstanding women in business, celebrating their contributions and achievements in China's equity investment sector and the broader economy. Qiming Venture Partners and female leaders from its portfolio companies received multiple honors.

Qiming Venture Partners Partner Xin Wang, and Partner and RMB Fund General Manager Jia Yu earned multiple recognitions. Wang was selected for PEDaily's S50 2026 Women Investors special feature and China FOF Research Center's 2026 Best Female Direct Investment Fund Investor; Yu was named China FOF Research Center's 2026 Best Female IR.

Xin Wang, Partner at Qiming Venture Partners

Selected for

PEDaily S50 2026 Women Investors Special Feature

Zero2IPO's PEDaily turns its lens to women on the investment front lines with the "PEDaily S50 Women Investors Special Feature" — S is for She, the resilient rose; for Super, representing superpowers; for Smart, reflecting their intellectual brilliance; and for Shining, demonstrating their professional excellence.

---

Xin Wang, Partner at Qiming Venture Partners

Selected for

China FOF Research Center Best Female Direct Investment Fund Investor

Jia Yu, Partner and RMB Fund General Manager at Qiming Venture Partners

Named

China FOF Research Center Best Female IR

Drawing on existing data and research analysis, China FOF Research Center officially released its 2026 Outstanding Female Professionals series rankings to recognize exceptional women in the private equity fund-of-funds and fund industries and promote the healthy development of the equity investment sector.

---

Li Ni, Vice Chair of the Board and Chief Operating Officer of portfolio company Bilibili (NASDAQ:BILI, 09626.HK); Xiaochun Cao, General Manager of Tigermed (300347.SZ, 03347.HK); Rui Xu, Co-founder and Vice General Manager of HyperStrong; and Haoying Shi, Founder and CEO of YourHealth, were named to the 2026 Forbes China 100 Outstanding Businesswomen list.

Li Ni, Vice Chair of the Board and Chief Operating Officer of Bilibili Xiaochun Cao, General Manager of Tigermed Rui Xu, Co-founder and Vice General Manager of HyperStrong

Haoying Shi, Founder and CEO of YourHealth Named to the 2025 Forbes China 100 Outstanding Businesswomen

Forbes China published its 12th annual 100 Outstanding Businesswomen list. The study examined female executives at domestic listed companies, female leaders of multinational corporations in China, and female founders of unicorn companies. Through data analysis of candidates' business performance, capital market results, market scale, industry influence, and innovation — from a pool of thousands — the final 100 were selected for the "Forbes China 100 Outstanding Businesswomen."

Source | Compiled from PEDaily, China FOF Research Center, Forbes China

PAST HIGHLIGHTS

Salute to Women Entrepreneurs Qiming Weekly | Portfolio News in Brief Vol.08, 2026.3.10 Qiming Honors | 5 Qiming Venture Partners Investors Named to 2025 Forbes China 100 Venture Capitalists

Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total committed capital reaching $9.5 billion. Since its inception, the firm has focused on investing in outstanding early- and growth-stage companies in Technology and Healthcare.

To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have listed on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. More than 80 portfolio companies have become recognized unicorns or super-unicorns.

Many Qiming Venture Partners portfolio companies have grown into the most influential companies in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), Hesai Technology (NASDAQ:HSAI, 02525.HK), UBTECH (09880.HK), WeRide (NASDAQ:WRD, 0800.HK), HyperStrong (688411.SH), Insta360 (688775.SH), Unisound (09678.HK), Biren Technology (06082.HK), Zhipu (02513.HK), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), SinoCellTech (688520.SH), Insilico Medicine (03696.HK), AusperBio, Yuanxin Technology, MediLink Therapeutics, LaNova Medicines, StepFun, and others.